These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 375186
1. [Real or alleged risks of clofibrate derivatives and certain risks of their prohibition]. de Gennes JL. Nouv Presse Med; 1979 Mar 31; 8(15):1223-5. PubMed ID: 375186 [No Abstract] [Full Text] [Related]
2. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V. Minerva Cardioangiol; 1980 Nov 31; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related]
3. [Is hypolipemic treatment effective as a preventive measure?]. Rywik S. Przegl Lek; 1989 Nov 31; 46(7):619-23. PubMed ID: 2685917 [No Abstract] [Full Text] [Related]
4. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. Br Heart J; 1978 Oct 31; 40(10):1069-118. PubMed ID: 361054 [No Abstract] [Full Text] [Related]
5. The clofibrate trial--the lipid hypothesis retested. Med J Aust; 1979 Jun 02; 1(11):490-1. PubMed ID: 381862 [No Abstract] [Full Text] [Related]
6. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around. Fejfar Z. Cor Vasa; 1979 Jun 02; 21(6):377-9. PubMed ID: 397875 [No Abstract] [Full Text] [Related]
7. Clofibrate: a final verdict? Lancet; 1978 Nov 25; 2(8100):1131-2. PubMed ID: 82687 [No Abstract] [Full Text] [Related]
8. [Current treatment with clofibrate or clofibric acid (Regadrin)]. Reuter W. Z Arztl Fortbild (Jena); 1982 May 15; 76(10):437-41. PubMed ID: 7136026 [No Abstract] [Full Text] [Related]
9. Cholesterol, coronaries, clofibrate and death. Oliver MF. N Engl J Med; 1978 Dec 14; 299(24):1360-2. PubMed ID: 362204 [No Abstract] [Full Text] [Related]
10. [Etofibrate and clofibrate in double blind study]. Rahlfs VW, Zimmermann H, Safer A. Dtsch Med Wochenschr; 1976 Jul 30; 101(31):1168-9. PubMed ID: 789039 [No Abstract] [Full Text] [Related]
11. [Increased mortality with clofibrate]. Wedel H, Vedin A, Wilhelmsen L. Lakartidningen; 1979 Jan 31; 76(5):273-4. PubMed ID: 366304 [No Abstract] [Full Text] [Related]
12. [The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini]. Kritchevsky D. Minerva Med; 1979 Dec 08; 70(55):3808-9. PubMed ID: 523009 [No Abstract] [Full Text] [Related]
13. [Short-term pilot study of the feasibility of multifactor reduction of coronary risk]. Menotti A, Puddu V. G Ital Cardiol; 1973 Dec 08; 3(2):206-19. PubMed ID: 4197329 [No Abstract] [Full Text] [Related]
14. Letter: Clofibrate and gallstones. Cooper J, Geizerova H, Oliver MF. Lancet; 1975 May 10; 1(7915):1083. PubMed ID: 48743 [No Abstract] [Full Text] [Related]
15. Hypolipaemic drugs and coronary heart disease. Howard AN. J Clin Pathol Suppl (R Coll Pathol); 1975 May 10; 9():106-14. PubMed ID: 783209 [No Abstract] [Full Text] [Related]
16. Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man. Cohn K, Sakai FJ, Langston MF. Am Heart J; 1975 May 10; 89(5):591-8. PubMed ID: 1091127 [Abstract] [Full Text] [Related]
17. Prevention of coronary heart disease--propaganda, promises, problems, and prospects. Oliver MF. Circulation; 1986 Jan 10; 73(1):1-9. PubMed ID: 3510083 [No Abstract] [Full Text] [Related]
18. Clofibrate for prevention of myocardial infarction. Med Lett Drugs Ther; 1973 Apr 27; 15(9):37-8. PubMed ID: 4704699 [No Abstract] [Full Text] [Related]
19. [Effect of a new lipid-reducing preparation (Etofibrat) on hyperlipoproteinemia type II. 2]. Knüchel F. Med Welt; 1974 Nov 01; 25(44):1810-2. PubMed ID: 4372508 [No Abstract] [Full Text] [Related]
20. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia]. Carlson LA, Olsson AG, Orö L, Rössner S. Lakartidningen; 1974 Sep 04; 71(36):3289-91. PubMed ID: 4605566 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]